Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Bertholet

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|April 10, 2018
Novel Platforms for the Development of a Universal Influenza VaccineArun Kumar, Trine Sundebo Meldgaard, Sylvie Bertholet
Microbial Pathogenesis|December 23, 2003
Impairment of Brucella growth in human macrophagic cells that produce nitric oxideAntoine Gross, Sylvie Bertholet, Jacques Mauel, et al.
Trends in Immunology|December 9, 2008
New horizons in adjuvants for vaccine developmentSteven G Reed, Sylvie Bertholet, Rhea N Coler, et al.
NPJ Vaccines|October 7, 2020
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccinesGiuseppe Lofano, Corey P Mallett, Sylvie Bertholet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvantsCharles Maisonneuve, Sylvie Bertholet, Dana J Philpott, et al.
Frontiers in Immunology|July 16, 2015
B Cells and Functional Antibody Responses to Combat InfluenzaGiuseppe Lofano, Arun Kumar, Oretta Finco, et al.
Vaccine|April 8, 2016
Anticipating policy considerations for a future HIV vaccine: a preliminary studyEmmanuel Ato Williams, David J M Lewis, Sylvie Bertholet, et al.
International Journal for Parasitology|April 3, 2003
Programmed cell death in trypanosomatids and other unicellular organismsAlain Debrabant, Nancy Lee, Sylvie Bertholet, et al.
Vaccine|September 7, 2007
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantYasuyuki Goto, Lisa Y Bogatzki, Sylvie Bertholet, et al.
Infection and Immunity|March 26, 2003
Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activationSylvie Bertholet, Harold L Dickensheets, Faruk Sheikh, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|April 10, 2018
Novel Platforms for the Development of a Universal Influenza VaccineArun Kumar, Trine Sundebo Meldgaard, Sylvie Bertholet
Microbial Pathogenesis|December 23, 2003
Impairment of Brucella growth in human macrophagic cells that produce nitric oxideAntoine Gross, Sylvie Bertholet, Jacques Mauel, et al.
Trends in Immunology|December 9, 2008
New horizons in adjuvants for vaccine developmentSteven G Reed, Sylvie Bertholet, Rhea N Coler, et al.
NPJ Vaccines|October 7, 2020
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccinesGiuseppe Lofano, Corey P Mallett, Sylvie Bertholet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvantsCharles Maisonneuve, Sylvie Bertholet, Dana J Philpott, et al.
Frontiers in Immunology|July 16, 2015
B Cells and Functional Antibody Responses to Combat InfluenzaGiuseppe Lofano, Arun Kumar, Oretta Finco, et al.
Vaccine|April 8, 2016
Anticipating policy considerations for a future HIV vaccine: a preliminary studyEmmanuel Ato Williams, David J M Lewis, Sylvie Bertholet, et al.
International Journal for Parasitology|April 3, 2003
Programmed cell death in trypanosomatids and other unicellular organismsAlain Debrabant, Nancy Lee, Sylvie Bertholet, et al.
Vaccine|September 7, 2007
Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantYasuyuki Goto, Lisa Y Bogatzki, Sylvie Bertholet, et al.
Infection and Immunity|March 26, 2003
Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activationSylvie Bertholet, Harold L Dickensheets, Faruk Sheikh, et al.
Pageof 7